A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts

Acta Medica Okayama

Volumn 67, Issue 1, 2013, Pages 45-53

  Hashizume, Hiroaki ^a   Sato, Ken ^a   Yamazaki, Yuichi ^a   Horiguchi, Norio ^a   Kakizaki, Satoru ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis c; Female; Nonalcoholic steatohepatitis; Prognosis

Indexed keywords

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; FATTY LIVER; FEMALE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MIDDLE AGED; MORTALITY; NONALCOHOLIC FATTY LIVER; PROGNOSIS; PROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; FATTY LIVER; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

HEPATITIS C VIRUS;

EID: 84875856426     PISSN: 0386300X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ong JP and Younossi ZM: Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis (2007) 11: 1-16.
2. Sass DA, Chang P and Chopra KB: Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci (2005) 50: 171-180.
3. Clark JM, Brancati FL and Diehl AM: The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol (2003) 98: 960-967.
4. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM and Hobbs HH: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 40: 1387-1395.
5. Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, Li JQ and Chen SY: Prevalence of nonalcoholic fatty liver among admin-strative officers in Shanghai: an epidemiological survey. World J Gastroenterol (2003) 9: 1106-1110.
6. Omagari K, Kadokawa Y, MasudaJ, Egawa I, SawaT, Hazama H Ohba K, Isomoto H, MizutaY, Hayashida K, Murase K, Kadota T. Murata I and Kohno S: Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol (2002) 17: 1098-1105.
7. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S and Goto M: Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med (1988) 27: 142-149.
8. Ground KE: Liver pathology in aircrew. Aviat Space Environ Med (1982)53: 14-18.
9. Hilden M, Christoffersen P, Juhl E and Dalgaard JB: Liver histology in a 'normal' population-examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol (1977) 12: 593-597.
10. Lai SW, Tan CK and Ng KC: Epidemiology of fatty liver in a hospital-based study in Taiwan. South Med J (2002) 95: 1288-1292
11. Nonomura A, Mizukami Y, Unoura M, Kobayashi K, Takeda Y and Takeda R: Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis. Gastroenterol Jpn (1992) 27: 521-528.
12. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G and Bellentani S: Prevalence of and risk factors for nonalcoholic fatty iver disease: the Dionysos nutrition and liver study. Hepatology (2005)42: 44-52.
13. Hashimoto E and Tokushige K: Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol (2011) 46: 63-69.
14. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M Manini R, Natale S, Vanni E, Villanova N, Melchionda N and Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology (2003) 37: 917-923
15. Ludwig J, Viggiano TR, McGill DB and Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc (1980) 55: 434-438.
16. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N Cassader M, David E, Cavallo-Perin P and Rizzetto M: Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology (2002) 35: 367-372.
17. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG and De Moura MC: Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr (1999) 18: 353-358.
18. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C Weltman M and George J: NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology (2002) 35: 373-379
19. Starley BQ, Calcagno CJ and Harrison SA: Nonalcoholic fatty iver disease and hepatocellular carcinoma: a weighty connection. Hepatology (2010)51: 1820-1832.
20. Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 348: 1625-1638.
21. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M and Rizzetto M: Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology (2002) 123: 134-140.
22. Hashimoto E, Yatsuji S, Tobari M, Taniai M, Torii N, Tokushige K and Shiratori K: Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol (2009) 44: 89-95.
23. Caldwell SH, Crespo DM, Kang HS and Al-Osaimi AM: Obesity and hepatocellular carcinoma. Gastroenterology (2004) 127: S97-103.
24. Lew EA and Garfinkel L: Variations in mortality by weight among 750,000 men and women. J Chronic Dis (1979) 32: 563-576.
25. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK: Fraumeni JF and Adam HO: A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 12: 13-21
26. Adams LA, Sanderson S, Lindor KD and Angulo P: The histologi-cal course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol (2005) 42 132-138.
27. Jones PH: Management of obesity in the prevention of cardiovascular disease. Methodist Debakey Cardiovasc J (2010) 6: 33-36.
28. Uchiyama S, Shibata Y, Hirabayashi T, Mihara B, Hamashige N Kitagawa K, Goto S, Origasa H, Shimada K, Kobayashi H Isozaki M and Ikeda Y: J-TRACE Investigators. Risk factor profiles of stroke, myocardial infarction, and atrial fibrillation: a Japanese Multicenter Cooperative Registry. J Stroke Cerebrovasc Dis (2010)19: 190-197.
29. Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K and Shiratori K: Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol (2009) 24: 248-254.
30. Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y. Shima T, Kanbara Y, Saibara T, Mori T, Kawata S, Uto H Takami S, Sumida Y, Takamura T, Kawanaka M, Okanoue T: Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol (2011) 9: 428-433.
31. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF and Zein NN: The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology (2010)51: 1972-1978.
32. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T. Yamada G, Hino K, Yokosuka O and Suzuki H: New Inuyama Classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun (1996) 6: 112-119.
33. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA and Bacon BR: Nonalcoholic steatohepatitis: a proposal for grad-ing and staging the histological lesions. Am J Gastroenterol (1999) 94: 2467-2474.
34. Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P. Khan M and George J: Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology (2003) 38: 420-427.
35. Sanyal AJ, Banas C, Sargeant C, Luketic VA, Sterling RK: Stravitz RT, Shiftman ML, Heuman D, Coterrell A, Fisher RA: Contos MJ and Mills AS: Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C Hepatology (2006) 43: 682-689.
36. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS Rosner B, Arky RA, Speizer FE and Hennekens CH: A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med (1991) 151 1141-1147.
37. Sasaki A, Horiuchi N, Hasegawa K and Uehara M: Mortality from coronary heart disease and cerebrovascular disease and associated risk factors in diabetic patients in Osaka District, Japan. Diabetes Res Clin Pract (1995) 27: 77-83.
38. Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S. Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A. Gemma L, Santi L, Bonadonna RC and Muggeo M: The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet Med (2004) 21: 52-58.
39. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M Bodemar G and Kechagias S: Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (2006) 44: 865-873.
40. Soderberg C, Stal P, AsklingJ, Glaumann H, Lindberg G, Marmur J and Hultcrantz R: Decreased survival of subjects with elevated iver function tests during a 28-year follow-up. Hepatology (2010) 51: 595-602.
41. Hashizume H, Sato K, Takagi H, HirokawaT, KojimaA, Sohara N Kakizaki S, Mochida Y, Shimura T, Sunose Y, Ohwada S and Mori M: Primary liver cancers with nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol (2007) 19: 827-834.